2026. IMPACT OF GLP-1 RECEPTOR AGONISTS ON LIVER ENZYMES AND FIBROSIS SCORES IN TYPE 2 DIABETIC AND NON-DIABETIC PATIENTS WITH FATTY LIVER DISEASE. Frontier in Medical and Health Research. 4, 3 (Mar. 2026), 4646–4654.